TITLE

ELECTROMYOGRAPHY AND MOTOR NERVE CONDUCTION VELOCITY IN PERIPHERAL ATHEROSCLEROSIS OBLITERANS

AUTHOR(S)
Chaco, Joshua
PUB. DATE
April 1969
SOURCE
Angiology;Apr1969, Vol. 20 Issue 4, p195
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Thirty patients with atherosclerosis obliterans of the peripheral arteries in both lower limbs wore examined. All the patients were found to be normal on clinical neurologic examination. The correlation between the vascular pathology and the ischemic impact on the peripheral nerves was determined by electromyography and motor nerve conduction velocity tests. The main points evolving from this study are: (1) The rate of subclinical damage to the peripheral nerves in patients with peripheral atherosclerosis obliterans is very high. (2) The test of preference to prove this damage is motor nerve conduction velocity which was found to be much more sensitive in comparison to electromyography. (3) Damage to the nerve in patients with intermittent claudication is much more pronounced than in patients with atherosclerosis obliterans but without intermittent claudication.
ACCESSION #
16407266

 

Related Articles

  • ELECTRONEUROGRAPHY IN INTERMITTENT CLAUDICATION DUE TO OBLITERATIVE ARTERIOSCLEROSIS. Kumlin, T.; Seppäläinen, A. M.; Railo, J. // Angiology;Jun1974, Vol. 25 Issue 6, p373 

    Studies on electromyographic changes in the lower limbs have been published in connection with obliterative arterial changes, because the blood supply of the sciatic nerve and its branches has its origin in the common iliac artery. Previous studies have dealt with maximal motor conduction and no...

  • A focus on risk factor management. Belch, Jill J. F.; Creager, Mark A. // Vascular Medicine;2004, Vol. 9 Issue 3, p169 

    This article reports that peripheral arterial disease (PAD) and its most common manifestation, intermittent claudication (IC), are associated with considerable morbidity and mortality. The patient with PAD has well-documented risk factors for atherosclerosis. Because of these, combined with the...

  • Efficacy of Cilostazol for Intermittent Claudication. Apgar, Barbara // American Family Physician;2/15/2000, Vol. 61 Issue 4, p1124 

    Discusses the study `A New Pharmacological Treatment for Intermittent Claudication: Results of a Randomized, Multicenter Trial,' by H.G. Beebe and colleagues published in the September 27, 1999 issue of the `Archives of Internal Medicine.'

  • Biochemical and inflammatory changes in the exercising claudicant. Tisi, P.V.; Shearman, C.P. // Vascular Medicine;1998, Vol. 3 Issue 3, p189 

    Intermittent claudication is an early manifestation of atherosclerosis in the leg. The prognosis for the claudicating limb is reasonably good, but patients have excess cardiovascular morbidity and mortality rates compared with a control population. Increasing evidence suggests that the calf pain...

  • Anticardiolipin Antibodies as a Risk Factor of Atherosclerosis in Intermittent Claudication. Pereira de Godoy, José Maria; Batigália, Fernando; Pereira de Godoy, Maria Regina; Brandão, Antonio Carlos; Souza, Dorotéia R. S. // Angiology;Jul/Aug2004, Vol. 55 Issue 4, p357 

    Anticardiolipin antibodies have been associated as a risk factor of atherosclerosis. The aim of this study was to evaluate the association between anticardiolipin antibodies and intermittent claudication. Forty consecutive patients (33 men, 7 women; age range: 45–84 years, mean 65.5) who...

  • Pharmacotherapy for Peripheral Arterial Disease: Emerging Therapeutic Options. Jaff, Michael R. // Angiology;Nov/Dec2002, Vol. 53 Issue 6, p627 

    Although endovascular therapy has revolutionized the management of patients with peripheral arterial disease (PAD), noninterventional regimens, such as structured exercise therapy, atherosclerotic risk factor modification, and pharmacotherapy, are effective in patients suffering from...

  • Pharmacological Management of Intermittent Claudication: A Meta-Analysis of Randomised Trials. Moher, D.; Pham, B.; Ausejo, M.; Saenz, A.; Hood, S.; Barber, G.G. // Drugs;May2000, Vol. 59 Issue 5, p1057 

    Intermittent claudication, a symptom of atherosclerosis in the large vessels of the lower limbs, greatly affects patient mobility and quality of life. Medical therapy for a moderate form of this condition includes vasodilators, antiplatelet agents and alternative treatments such as ginkgo...

  • Peripheral neuropathy in CADASIL. Sicurelli, Francesco; Dotti, Maria Teresa; De Stefano, Nicola; Malandrini, Alessandro; Mondelli, Mauro; Bianchi, Silvia; Federico, Antonio // Journal of Neurology;Oct2005, Vol. 252 Issue 10, p1206 

    Background Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) is a hereditary cerebral microangiopathy associated with mutations in the Notch 3 gene. The clinical phenotype is characterized by cerebral impairment even though typical microvascular...

  • A Comparative Analysis of Transcutaneous Oxygen Tension (tcPo2) During Rest and Postischemic Response Test in the Diagnosis of Patients with Mild and Moderate Arteriosclerosis Obliterans (ASO). Qian, Shuixian; Iwai, Takehisa; Inoue, Yoshinori; Endo, Mitsuo // Vascular Surgery;Jul/Aug1994, Vol. 28 Issue 6, p393 

    Transcutaneous oxygen tension (tcPo2) was measured at the foot and chest wall in 12 normal subjects and 62 patients with arteriosclerosis obliterans (ASO). The results showed that the resting tcPo2 at the foot and the chest wall was significantly lower in asymptomatic patients (p < 0.01 at the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics